<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="215041">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00286221</url>
  </required_header>
  <id_info>
    <org_study_id>00001283</org_study_id>
    <nct_id>NCT00286221</nct_id>
  </id_info>
  <brief_title>IVPCA in the Management of Pain Following Major Intracranial Surgery</brief_title>
  <official_title>The Safety and Efficacy of IVPCA in the Management of Adult Postoperative Craniotomy Pain: A Prospective, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <brief_summary>
    <textblock>
      This is a prospective, randomized controlled clinical trial to evaluate the efficacy and
      safety of intravenous patient controlled analgesia (IVPCA) in patients following major
      intracranial surgery (e.g. brain tumors, vascular surgery). We will compare pain, opioid
      consumption, costs, sedation level, length of hospital stay, patient satisfaction, and
      complications in patients randomized to receive either PRN or IVPCA opioids. We hypothesize
      that IVPCA will be more efficacious than PRN opioids in the treatment of postoperative
      without an increased incidence of adverse effects.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2006</start_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Sedation</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antihypertensive drug administration</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid administration</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea/vomiting</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pruritus</measure>
  </secondary_outcome>
  <enrollment>128</enrollment>
  <condition>Intracranial Surgery</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IVPCA fentanyl</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PRN fentanyl</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adults undergoing intracranial surgery

        Exclusion Criteria:

        Patient refusal

        Aphasia Respiratory failure

        Allergy/intolerance to fentanyl

        Opioids use

        Patient has been in an investigational drug trial (except chemotherapy) in the month
        preceding the day of enrollment

        Patient is unable to initiate a bolus dose of IVPCA fentanyl
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Myron Yaster, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert D Stevens, MD</last_name>
    <phone>(410) 955 2611</phone>
    <email>rstevens@jhmi.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Myron Yaster, MD</last_name>
    <phone>(410) 955 2393</phone>
    <email>myaster@jhmi.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2006</verification_date>
  <lastchanged_date>February 1, 2006</lastchanged_date>
  <firstreceived_date>February 1, 2006</firstreceived_date>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
